Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Ljubljana | OTHER |
| General Hospital Murska Sobota | OTHER |
| Maastricht University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to evaluate prevalence of sarcopenia and cachexia in patients with chronic cardiopulmonary disease. The investigators will also investigate metabolic disorders like glucose metabolism, presence of metabolic syndrome, body composition and histological changes in skeletal muscle and body fat. Finally, patients will be followed for clinical endpoints.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Heart failure | |||
| Chronic obstructive pulmonary disease | |||
| Chronic kidney disease | |||
| Malignancy | |||
| Controls |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Insulin resistance (HOMA-IR) | HOMA-IR as calculated by formula using insulin and blood glucose | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Muscle strength (Handgrip test) | Handgrip test | Baseline |
| Change in exercise capacity (6 minute walk test) | Determined by incremental exercise test, 6 minute walk test |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with chronic disease (Heart failure, COPD, malignancy, CKD) and healthy controls
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mitja Lainscak | Contact | mitja.lainscak@guest.arnes.si |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| General Hospital Celje | Recruiting | Celje | SI-3000 | Slovenia |
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D009369 | Neoplasms |
| D051436 | Renal Insufficiency, Chronic |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Serum; plasma; Skeletal muscle; fat tissue; urine; full blood
| baseline and after 5 weeks |
| Neurohormonal activation (NT-proBNP concentration) | NT-proBNP concentration | Baseline |
| Change in apoptosis in skeletal muscle (number of apoptotic cells per square mm) | histological evaluation: number of apoptotic cells per square mm | Baseline and after 5 weeks |
| Change in insulin resistance (HOMA-IR) | HOMA-IR as calculated by formula using insulin and blood glucose | Baseline and after 5 weeks |
| D012140 |
| Respiratory Tract Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |